Rabusertib

Rabusertib is an inhibitor of the cell cycle checkpoint kinase 1 (chk1) with potential chemopotentiating activity. Rabusertib has been used in trials studying the treatment of Cancer, Solid Tumors, Advanced Cancer, Pancreatic Neoplasms, and Non-Small Cell Lung Cancer.

Price Not Available 50 mg Rabusertib Supplier Page

Catalog Number	T6084
Alternative Name(s)	LY2603618 , IC-83
Research Area	PI3K/Akt/mTOR signaling\|\|\|Autophagy\|\|\|Cell Cycle/Checkpoint
Molecular Formula	C18H22BrN5O3
CAS#	911222-45-2
Purity	99.40%
SMILES	Cc1cc(c(cc1Br)NC(=O)Nc1ncc(nc1)C)OC[C@@H]1CNCCO1
Size	50 mg
Supplier Page	https://www.targetmol.com/compound/Rabusertib
Additional Information	https://www.targetmol.com/datasheet/T6084